Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003469 · ClinicalTrials.gov registry record · NA
Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02003469 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 67 participants.
The verdict
NCT02003469, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
Background and Rationale Cardiovascular disease is highly prevalent in the kidney transplant population, accounting for approximately 40% of all deaths and significant morbidity. The morbidity and mortality experienced by kidney transplant recipient's results from an excess of pre-transplant risk factors that are exacerbated by kidney transplantation along with the development of novel risk factors. Hypertension (HTN) is the most consistent cardiovascuar disease risk factor in transplant recipients.. A large number of studies have been done in the general population comparing ambulatory blood pressure monitoring (ABPM) to casual, office based and home measures of blood pressure (BP). The results have clearly demonstrated that ABPM gives a more accurate representation of BP and arguably should be used as part of routine patient care. ABPM has been shown to reveal patients both with white-coat and with masked HTN, nocturnal HTN and lack of nocturnal dipping. Ambulatory BP measures afford us a non-invasive, highly accurate way to evaluate and treat kidney transplant recipients. Live kidney donors (LKD) have significantly expanded the supply of critical organs. Of paramount importance of course has always been donor safety. As a result, candidates are known to be healthy at the time of donation. Ambulatory blood pressure monitoring allows a unique opportunity to examine the effects of live kidney donation on the blood pressure profiles of LKD. Methods Study Design: Prospective, 5-year, single center study of ABPM, cardiovascular and graft outcomes in incident and prevalent live kidney donors, kidney and kidney-pancreas transplant candidates and recipients.
Interventions
- DEVICE Ambulatory Blood Pressure Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003469
The ClinicalTrials.gov registry entry for NCT02003469 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ambulatory Blood Pressure Monitoring is the first listed.
NCT02003469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003469 about?
NCT02003469 is a clinical study titled "Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II". Background and Rationale Cardiovascular disease is highly prevalent in the kidney transplant population, accounting for approximately 40% of all deaths and significant morbidity. The morbidity and mortality experienced by kidney transplant recipient's results from an excess of pre-transplant risk fa...
What is the current status of trial NCT02003469?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2009-04. Estimated completion is 2013-09.
What interventions are being tested in trial NCT02003469?
The interventions under investigation include: Ambulatory Blood Pressure Monitoring (DEVICE).
Who is sponsoring clinical trial NCT02003469?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.